z-logo
open-access-imgOpen Access
Systemic delivery of large-scale manufactured Wharton’s Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction
Author(s) -
Michael A. Bellio,
Rosemeire M. KanashiroTakeuchi,
Lauro M Takeuchi,
Shathiyah Kulandavelu,
YeeShuan Lee,
Wayne Balkan,
Karen Young,
Joshua M. Hare,
Aisha Khan
Publication year - 2021
Publication title -
the journal of cardiovascular aging
Language(s) - English
Resource type - Journals
ISSN - 2768-5993
DOI - 10.20517/jca.2021.21
Subject(s) - wharton's jelly , mesenchymal stem cell , extracellular vesicles , myocardial infarction , cardiac function curve , vesicle , function (biology) , microvesicles , chemistry , cardiology , microbiology and biotechnology , medicine , biology , heart failure , biochemistry , microrna , membrane , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom